Display options
Cite
Abid S, Ali S, Baig MA, et al. Is it time to replace propranolol with carvedilol for portal hypertension?. World J Gastrointest Endosc. 2015;7(5):532-9doi: 10.4253/wjge.v7.i5.532.
Abid, S., Ali, S., Baig, M. A., & Waheed, A. A. (2015). Is it time to replace propranolol with carvedilol for portal hypertension?. World journal of gastrointestinal endoscopy, 7(5), 532-9. https://doi.org/10.4253/wjge.v7.i5.532
Abid, Shahab, et al. "Is it time to replace propranolol with carvedilol for portal hypertension?." World journal of gastrointestinal endoscopy vol. 7,5 (2015): 532-9. doi: https://doi.org/10.4253/wjge.v7.i5.532
Abid S, Ali S, Baig MA, Waheed AA. Is it time to replace propranolol with carvedilol for portal hypertension?. World J Gastrointest Endosc. 2015 May 16;7(5):532-9. doi: 10.4253/wjge.v7.i5.532. PMID: 25992192; PMCID: PMC4436921.
Copy Download .nbib Format: NLM
Share it on

World J Gastrointest Endosc. 2015 May 16;7(5):532-9. doi: 10.4253/wjge.v7.i5.532.

Is it time to replace propranolol with carvedilol for portal hypertension?.

World journal of gastrointestinal endoscopy

Shahab Abid, Saadat Ali, Muhammad Asif Baig, Anam Akbar Waheed

Affiliations

  1. Shahab Abid, Saadat Ali, Muhammad Asif Baig, Anam Akbar Waheed, Section of Gastroenterology, Department of Medicine, Aga Khan University, Karachi 74800, Pakistan.

PMID: 25992192 PMCID: PMC4436921 DOI: 10.4253/wjge.v7.i5.532

Abstract

Beta-adrenergic receptor antagonists (β-blockers) have been well established for use in portal hypertension for more than three decades. Different Non-selective β-blockers like propranolol, nadolol, timolol, atenolol, metoprolol and carvedilol have been in clinical practice in patients with cirrhosis. Carvedilol has proven 2-4 times more potent than propranolol as a beta-receptor blocker in trials conducted testing its efficacy for heart failure. Whether the same effect extends to its potency in the reduction of portal venous pressures is a topic of on-going debate. The aim of this review is to compare the hemodynamic and clinical effects of carvedilol with propranolol, and attempt assess whether carvedilol can be used instead of propranolol in patients with cirrhosis. Carvedilol is a promising agent among the beta blockers of recent time that has shown significant effects in portal hypertension hemodynamics. It has also demonstrated an effective profile in its clinical application specifically for the prevention of variceal bleeding. Carvedilol has more potent desired physiological effects when compared to Propranolol. However, it is uncertain at the present juncture whether the improvement in hemodynamics also translates into a decreased rate of disease progression and complications when compared to propranolol. Currently Carvedilol shows promise as a therapy for portal hypertension but more clinical trials need to be carried out before we can consider it as a superior option and a replacement for propranolol.

Keywords: Carvedilol; Chronic liver disease; Non-selective beta-blockers; Portal hypertension; Propranolol

References

  1. J Gastroenterol Hepatol. 2002 Feb;17(2):183-9 - PubMed
  2. Eur J Gastroenterol Hepatol. 1999 Jul;11(7):741-5 - PubMed
  3. Hepatology. 1991 May;13(5):902-12 - PubMed
  4. J Clin Invest. 1991 Mar;87(3):1032-6 - PubMed
  5. J Hepatol. 2005 Jan;42(1):146-7; author reply 147-8 - PubMed
  6. Hepatology. 2007 Sep;46(3):922-38 - PubMed
  7. N Engl J Med. 1998 Dec 10;339(24):1759-65 - PubMed
  8. Hepatology. 2010 Sep;52(3):1017-22 - PubMed
  9. Gastroenterology. 1997 Jun;112(6):2012-6 - PubMed
  10. J Coll Physicians Surg Pak. 2009 May;19(5):283-6 - PubMed
  11. Lancet. 1980 Jul 26;2(8187):180-2 - PubMed
  12. N Engl J Med. 1987 Oct 1;317(14):856-61 - PubMed
  13. Am J Gastroenterol. 2004 Oct;99(10):1959-65 - PubMed
  14. Scand J Gastroenterol. 2012 Apr;47(4):467-74 - PubMed
  15. Hepatology. 2009 Sep;50(3):825-33 - PubMed
  16. Am J Gastroenterol. 2000 Oct;95(10):2888-93 - PubMed
  17. Hepatology. 1997 Jan;25(1):63-70 - PubMed
  18. Am J Gastroenterol. 2004 Oct;99(10 ):1953-8 - PubMed
  19. J Hepatol. 2014 Nov;61(5):1014-9 - PubMed
  20. J Hepatol. 1991 Sep;13(2):213-9 - PubMed
  21. Lancet. 2012 Dec 15;380(9859):2095-128 - PubMed
  22. J Hepatol. 2010 Jun;52(6):946-8 - PubMed
  23. Hepatology. 1999 Jul;30(1):79-83 - PubMed
  24. J Hepatol. 2010 Oct;53(4):762-8 - PubMed
  25. Aliment Pharmacol Ther. 2008 Oct 15;28(8):943-52 - PubMed
  26. Hepatology. 2008 May;47(5):1764-72 - PubMed
  27. Gastroenterology. 1997 Feb;112(2):473-82 - PubMed
  28. Lancet. 1995 Oct 21;346(8982):1056-9 - PubMed
  29. Lancet. 1991 Jun 15;337(8755):1431-4 - PubMed
  30. Gastroenterology. 2006 Nov;131(5):1611-24 - PubMed
  31. J Hepatol. 2014 Apr;60(4):757-64 - PubMed
  32. J Hepatol. 2002 Feb;36(2):148-50 - PubMed
  33. Hepatology. 2003 Apr;37(4):902-8 - PubMed
  34. Hepatology. 2002 Dec;36(6):1367-73 - PubMed
  35. World J Gastroenterol. 2003 Aug;9(8):1836-9 - PubMed
  36. Gastroenterology. 2014 Jun;146(7):1680-90.e1 - PubMed
  37. Gastroenterology. 2000 Jul;119(1):181-7 - PubMed
  38. Hepatology. 1993 Nov;18(5):1082-9 - PubMed
  39. Aliment Pharmacol Ther. 2014 Mar;39(6):557-68 - PubMed
  40. Liver Int. 2014 May;34(5):655-67 - PubMed
  41. Hepatology. 1989 Aug;10(2):257-8 - PubMed
  42. N Engl J Med. 2005 Nov 24;353(21):2254-61 - PubMed
  43. N Engl J Med. 1991 May 30;324(22):1532-8 - PubMed
  44. Liver Int. 2009 Sep;29(8):1189-93 - PubMed
  45. J Gastroenterol Hepatol. 2012 Nov;27(11):1681-7 - PubMed
  46. Semin Liver Dis. 1999;19(4):475-505 - PubMed
  47. Gut. 2013 Nov;62(11):1634-41 - PubMed
  48. Nat Rev Gastroenterol Hepatol. 2009 Dec;6(12):692-4 - PubMed
  49. N Engl J Med. 2010 Mar 4;362(9):823-32 - PubMed

Publication Types